FIELD: medicine.
SUBSTANCE: invention concerns medicine, in particular to endocrinology, and relate to treatment of 2nd type diabetes complicated by a polyneuropathy. For this purpose against basic complex therapy of diabetes in addition tylorone is entered on 250 mg/days into 1st and 2nd days of treatment. Further tylorone is administered on 125 mg in two days on the third. On course of treatment the preparation dose makes not less than 2500 mg.
EFFECT: for the first time the developed regimen of the chosen immunomodulator administration for the given contingent of patients allows to raise efficiency of treatment.
2 ex
